Effect of maternal reproductive factors on prenatal screening rates in the first trimester

Effect of maternal factors on indicators of increased risk of chromosomal abnormalities (CA), pre-eclampsia (PE), Small-forGestational-Age Fetus (SGA fetus) and preterm labour and birth (PB) during prenatal screening has not been sufficiently studied. Aim. To study the effect of maternal reproductiv...

Full description

Bibliographic Details
Main Authors: P. M. Samchuk, A. I. Ishchenko, E. L. Azoeva
Format: Article
Language:Russian
Published: Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) 2021-01-01
Series:Сеченовский вестник
Subjects:
Online Access:https://www.sechenovmedj.com/jour/article/view/152
id doaj-3defa762a4da4dc58658e0061bf14d5f
record_format Article
spelling doaj-3defa762a4da4dc58658e0061bf14d5f2021-09-16T17:42:57ZrusFederal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)Сеченовский вестник2218-73322658-33482021-01-01113374610.47093/2218-7332.2020.11.3.37-46146Effect of maternal reproductive factors on prenatal screening rates in the first trimesterP. M. Samchuk0A. I. Ishchenko1E. L. Azoeva2Sechenov First Moscow State Medical University (Sechenov University); Moscow State Clinical Hospital named after V.V. VeresaevSechenov First Moscow State Medical University (Sechenov University)Moscow State Clinical Hospital named after V.V. VeresaevEffect of maternal factors on indicators of increased risk of chromosomal abnormalities (CA), pre-eclampsia (PE), Small-forGestational-Age Fetus (SGA fetus) and preterm labour and birth (PB) during prenatal screening has not been sufficiently studied. Aim. To study the effect of maternal reproductive factors on the risk indicators of CA, PE, SGA fetus and PB, assessed during prenatal screening using the Astraia Obstetrics module. Materials and methods. Of the 11,841 pregnant women who were prenatal screened, 18.53% of the patients had at high risk of the outcomes studied (frequency 1: 100 and above). The subgroup of isolated high risk for CA included 69, PE — 66, SGA fetus — 48, PB — 52 patients. From the group of patients with low risk, 208 patients were selected for the control group by the method of stratified randomization by age. Results. Among extragenital diseases, the most common in all high-risk subgroups were: hypertension (AH) I and II degree — 31–47% versus 4.8% of the control group (p < 0.05), varicose veins of the lower extremities (VVLE) — 17–30% vs. 5.3% in the control group (p < 0.05), a history of ovarian tumor — 12–33% vs. 3% in the control group (p < 0.05). In the high-risk subgroups for the development of CA, PE and SGA fetus, fibroids uterus and iron deficiency anaemia (IDA) were more common compared to control: 10–41% vs. 1% (p < 0.05) and 10–17% vs. 3% (p < 0.05), respectively (p < 0.05). Primiparas with a history of pregnancy were more common in subgroups with a high risk of CA (33%) and PR (35%) versus 17% in controls. Conclusion. An association has been established between high risk for all the outcomes studied and AC, VVLE, history of ovarian tumor. High-risk subgroups for CA, PE and SGA fetus have a higher incidence of uterine fibroids and IDA compared to control.https://www.sechenovmedj.com/jour/article/view/152prenatal screeningpregnancy complicationsmaternal factorsa fetal medicine software program astraiachromosomal abnormalities
collection DOAJ
language Russian
format Article
sources DOAJ
author P. M. Samchuk
A. I. Ishchenko
E. L. Azoeva
spellingShingle P. M. Samchuk
A. I. Ishchenko
E. L. Azoeva
Effect of maternal reproductive factors on prenatal screening rates in the first trimester
Сеченовский вестник
prenatal screening
pregnancy complications
maternal factors
a fetal medicine software program astraia
chromosomal abnormalities
author_facet P. M. Samchuk
A. I. Ishchenko
E. L. Azoeva
author_sort P. M. Samchuk
title Effect of maternal reproductive factors on prenatal screening rates in the first trimester
title_short Effect of maternal reproductive factors on prenatal screening rates in the first trimester
title_full Effect of maternal reproductive factors on prenatal screening rates in the first trimester
title_fullStr Effect of maternal reproductive factors on prenatal screening rates in the first trimester
title_full_unstemmed Effect of maternal reproductive factors on prenatal screening rates in the first trimester
title_sort effect of maternal reproductive factors on prenatal screening rates in the first trimester
publisher Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
series Сеченовский вестник
issn 2218-7332
2658-3348
publishDate 2021-01-01
description Effect of maternal factors on indicators of increased risk of chromosomal abnormalities (CA), pre-eclampsia (PE), Small-forGestational-Age Fetus (SGA fetus) and preterm labour and birth (PB) during prenatal screening has not been sufficiently studied. Aim. To study the effect of maternal reproductive factors on the risk indicators of CA, PE, SGA fetus and PB, assessed during prenatal screening using the Astraia Obstetrics module. Materials and methods. Of the 11,841 pregnant women who were prenatal screened, 18.53% of the patients had at high risk of the outcomes studied (frequency 1: 100 and above). The subgroup of isolated high risk for CA included 69, PE — 66, SGA fetus — 48, PB — 52 patients. From the group of patients with low risk, 208 patients were selected for the control group by the method of stratified randomization by age. Results. Among extragenital diseases, the most common in all high-risk subgroups were: hypertension (AH) I and II degree — 31–47% versus 4.8% of the control group (p < 0.05), varicose veins of the lower extremities (VVLE) — 17–30% vs. 5.3% in the control group (p < 0.05), a history of ovarian tumor — 12–33% vs. 3% in the control group (p < 0.05). In the high-risk subgroups for the development of CA, PE and SGA fetus, fibroids uterus and iron deficiency anaemia (IDA) were more common compared to control: 10–41% vs. 1% (p < 0.05) and 10–17% vs. 3% (p < 0.05), respectively (p < 0.05). Primiparas with a history of pregnancy were more common in subgroups with a high risk of CA (33%) and PR (35%) versus 17% in controls. Conclusion. An association has been established between high risk for all the outcomes studied and AC, VVLE, history of ovarian tumor. High-risk subgroups for CA, PE and SGA fetus have a higher incidence of uterine fibroids and IDA compared to control.
topic prenatal screening
pregnancy complications
maternal factors
a fetal medicine software program astraia
chromosomal abnormalities
url https://www.sechenovmedj.com/jour/article/view/152
work_keys_str_mv AT pmsamchuk effectofmaternalreproductivefactorsonprenatalscreeningratesinthefirsttrimester
AT aiishchenko effectofmaternalreproductivefactorsonprenatalscreeningratesinthefirsttrimester
AT elazoeva effectofmaternalreproductivefactorsonprenatalscreeningratesinthefirsttrimester
_version_ 1717378138212663296